Topical application of 1,25-dihydroxyvitamin D3 (calcitriol) is an effective and reliable therapy to cure skin lesions in psoriatic children
- PMID: 8319701
- DOI: 10.1007/BF01955893
Topical application of 1,25-dihydroxyvitamin D3 (calcitriol) is an effective and reliable therapy to cure skin lesions in psoriatic children
Abstract
We studied, in vivo, the effects of a calcitriol-containing ointment (3 micrograms of calcitriol per gram of petrolatum) topically applied on skin lesions in children affected by psoriasis vulgaris. Each patient was instructed to apply the ointment, about 1 g once a day at bedtime followed by occlusive dressing with plastic wrap, on one-side lesion (treated) and petrolatum alone on the equivalent controlateral site (placebo) (total weekly dose of calcitriol: approximately 21 micrograms/patient). After 4 weeks of topical treatment all children showed a complete clearing of their skin lesions on the treated side, without appreciable changes on the placebo side. Serum ionised calcium, calcium and calcitriol levels or urinary calcium excretion did not vary significantly throughout the period of therapy. These findings suggest that topical calcitriol may be an effective and safe alternative therapy for psoriasis in children.
Similar articles
-
Calcitriol (1 alpha,25-dihydroxyvitamin D3) ointment in psoriasis, a safety tolerance and efficacy multicentre study.Dermatology. 1994;188(2):135-9. doi: 10.1159/000247118. Dermatology. 1994. PMID: 8136540 Clinical Trial.
-
Efficacy and safety of topical calcitriol (1,25-dihydroxyvitamin d3) for the treatment of psoriasis.Br J Dermatol. 1996 Feb;134(2):238-46. Br J Dermatol. 1996. PMID: 8746336 Clinical Trial.
-
Efficacy and safety of topical calcitriol 3 microg/g ointment, a new topical therapy for chronic plaque psoriasis.J Drugs Dermatol. 2009 Aug;8(8 Suppl):s9-16. J Drugs Dermatol. 2009. PMID: 19702031 Review.
-
Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies.J Drugs Dermatol. 2007 Apr;6(4):428-35. J Drugs Dermatol. 2007. PMID: 17668541 Clinical Trial.
-
Calcitriol 3 microg/g ointment: an effective and safe addition to the armamentarium in topical psoriasis therapy.J Drugs Dermatol. 2009 Aug;8(8 Suppl):s17-22. J Drugs Dermatol. 2009. PMID: 19702032 Review.
Cited by
-
Head-to-Head Comparison of Tazarotene and Calcitriol with or without Sequential Therapy in Mild-to-Moderate Psoriasis: A Randomized Open-label Study.J Res Pharm Pract. 2024 Jan 31;12(2):44-48. doi: 10.4103/jrpp.jrpp_10_23. eCollection 2023 Apr-Jun. J Res Pharm Pract. 2024. PMID: 38463187 Free PMC article.
-
Vitamin D analogs in the treatment of psoriasis: Where are we standing and where will we be going?Dermatoendocrinol. 2011 Jul;3(3):180-6. doi: 10.4161/derm.3.3.17534. Epub 2011 Jul 1. Dermatoendocrinol. 2011. PMID: 22110777 Free PMC article.
-
Adolescent Scalp Psoriasis: Update on Topical Combination Therapy.J Clin Aesthet Dermatol. 2015 Jul;8(7):43-7. J Clin Aesthet Dermatol. 2015. PMID: 26203320 Free PMC article. Review.
-
Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design.Comp Med. 2009 Apr;59(2):112-28. Comp Med. 2009. PMID: 19389303 Free PMC article.
-
[Children and adolescents with psoriasis. What therapy is recommended?].Hautarzt. 2012 Mar;63(3):192-201. doi: 10.1007/s00105-011-2229-3. Hautarzt. 2012. PMID: 22382304 Review. German.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical